Visioneering Technologies, Inc. Successfully Lists on ASX

ATLANTA--(BUSINESS WIRE)--Visioneering Technologies, Inc. (ASX:VTI), a US-based medical device company engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue™ Multifocal 1 Day (NaturalVue MF) contact lenses, has today listed on the Australian Securities Exchange after raising A$33.3 million following the close of its Initial Public Offer (IPO). The IPO was fully underwritten by Cannacord Genuity and strongly supported by institutional and sophisticated investors

Full Story →